Login
$PFE
$28.89 +$0.03 (0.1%) After hours

$PFE 8-K/A SEC Filings

Filed On Filing
14 Dec 2023 8-K/A: Completion of Acquisition or Disposition of Assets; Regulation FD Disclosure

Further establishes Pfizer as a leading oncology company poised to accelerate the next generation of breakthrough treatments for people with cancer

21 Dec 2017 8-K/A: Departure/Election of Directors or Officers; Compensation

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

14 Nov 2016 8-K/A: Other Events

NEW YORK, NY, November 14, 2016 — Pfizer Inc. (NYSE: PFE) today announced the commencement of a tender offer (the “Tender Offer”) to purchase for cash any and all of its outstanding 6.200% Senior Notes due March 15, 2019 (the “Notes”). C...

30 Jun 2003 8-K/A: Completion of Acquisition or Disposition of Assets
28 Apr 2003 8-K/A: Changes in Registrant's Certifying Accountant

Securities and Exchange Commission 450 Fifth Street, N. W. Washington, D. C. 20549

10 May 1995 8-K/A: Financial Statements and Exhibits

-------------------------------------------------------------------------------- --------------------------------------------------------------------------------

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support